Pink Sheet is part of the Informa Intelligence Division of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction

Lipitor v. Pravachol Studies Raise Questions On Utility Of OTC-Dose Statins

This article was originally published in The Tan Sheet

Executive Summary

Two recently published clinical trials involving statins that report a clear and substantial benefit from intensive LDL-cholesterol lowering versus moderate reduction may dampen prospects for switching the drugs OTC in the U.S
Advertisement

Related Content

Kos Statin/Niacin Fixed Dose Combo To Be Supported By NHLBI-Funded Trial
Kos Statin/Niacin Fixed Dose Combo To Be Supported By NHLBI-Funded Trial
Kos Statin/Niacin Fixed Dose Combo To Be Supported By NHLBI-Funded Trial
Simvastatin Myopathy Rate Spells Trouble For High Doses In “A to Z” Trial
Simvastatin Myopathy Rate Spells Trouble For High Doses In “A to Z” Trial
Simvastatin Myopathy Rate Spells Trouble For High Doses In “A to Z” Trial
Round Two: Mevacor Switch Will Need To Quiet Undertreatment Questions
Round Two: Mevacor Switch Will Need To Quiet Undertreatment Questions
Pravachol Lipid Reduction Falls Short Of Lipitor In Disease Progression Study
Pravachol Lipid Reduction Falls Short Of Lipitor In Disease Progression Study

Topics

Advertisement
UsernamePublicRestriction

Register

PS096584

Ask The Analyst

Please Note: You can also Click below Link for Ask the Analyst
Ask The Analyst

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel